Related Experiment Video

Updated: May 1, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

8.1K

Toll-like receptor expression and signaling in human diabetic wounds

Mohan R Dasu1, Sandra J Martin1

  • 1Mohan R Dasu, Department of Dermatology, University of California at Davis, Davis, CA 95816, United States.

World Journal of Diabetes
|April 22, 2014
PubMed
Abstract

Insights

Toll-like receptors (TLRs) are upregulated in diabetic wounds, contributing to prolonged inflammation. This study investigated TLR expression and activation in diabetic wound tissues.

Area of Science:

  • Immunology
  • Wound Healing
  • Diabetic Complications

Background:

  • Diabetic wounds exhibit prolonged inflammation, impairing healing.
  • Toll-like receptors (TLRs) are crucial in immune responses and inflammation.

Purpose of the Study:

  • To investigate the role of toll-like receptors (TLRs) expression and activation in diabetic wound hyperinflammation.
  • To quantify TLRs and associated inflammatory markers in human diabetic wounds.

Main Methods:

  • Collected debridement wound tissue from diabetic patients.
  • Utilized real-time polymerase chain reaction and Western blot analyses for gene and protein expression.
  • Measured inflammatory markers including cytokines and nuclear factor-kappa B activation.

Main Results:

  • Significantly increased mRNA expression of TLR1, TLR2, TLR4, and TLR6 in diabetic wounds.
  • Elevated MyD88 protein expression, a key TLR signaling molecule, in diabetic wounds.
  • Increased levels of Interleukin-1beta, tumor necrosis factor-alpha, nuclear factor-kappa B activation, and thiobarbituric acid reactive substances in diabetic wounds.

Conclusions:

  • Increased TLR expression, signaling, and activation are implicated in the hyperinflammation of human diabetic wounds.
  • These findings highlight TLRs as potential therapeutic targets for improving diabetic wound healing.
Keywords:
InflammationInterleukin-1βToll-like receptors 2Toll-like receptors 4Tumor necrosis factor-αType 2-diabetes mellitusWound healing

More Related Videos

Protocol to Create Chronic Wounds in Diabetic Mice06:55

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

20.8K
Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

8.1K

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28